• Mithra receives positive DSMB Opinion on DONESTA® European Phase 3 Trial

    Monday December 18th 2023

  • Sequana Medical announces positive data from non-randomized cohort in US Phase 1/2a MOJAVE study of DSR® 2.0 for treatment of heart failure

    Wednesday November 29th 2023

  • argenx reports topline results from ADVANCE-SC study of VYVGART Hytrulo in primary immune thrombocytopenia

    Tuesday November 28th 2023

  • Orionis Biosciences announces first patient dosed in Phase 1 clinical trial of ORB-011 in patients with advanced solid tumors

    Wednesday November 15th 2023

  • SwiftPharma and PlantForm target blockbuster cancer drug with new contract manufacturing agreement for plant-made biosimilars

    Tuesday November 14th 2023

  • Sequana Medical announces additional alfapump data supporting strong and durable clinical profile; PMA on track for year-end submission

    Thursday October 19th 2023

  • Sequana Medical announces initial positive data from MOJAVE, a US Phase 1/2a study of DSR® 2.0 for treatment of heart failure through breaking vicious cycle of cardiorenal syndrome

    Wednesday October 18th 2023

  • Agomab raises $100 million Series C to advance fibrosis-focused pipeline

    Wednesday October 11th 2023

  • Your news here?

  • SwiftPharma launches ODIN.AI: A groundbreaking AI-augmented antibody discovery platform

    Monday October 9th 2023

  • Agomab receives FDA Fast Track Designation for AGMB-129 in Fibrostenosing Crohn’s Disease and starts STENOVA Phase 2a clinical trial

    Friday October 6th 2023

  • Rejuvenate Biomed announces positive results from Phase 1b clinical trial with RJx-01 in sarcopenia

    Wednesday October 4th 2023

Strategic Partners